Get Started

CVKD

NASD Cadrenal Therapeutics, Inc.
Oct 27, 2026 · 2:12 AM ET EOD Market Closed

$0.9100 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.9100, $0.0500 below the day’s high of $0.9600

YTD change
-86.58%
vs 20-day SMA
-8.76%
vs 200-day SMA
-77.96%

Price ranges

Previous day
$0.9300 $1.0000
open $0.9650 close $0.9600
-$0.0050 (-0.52%)
Today
$0.9100 $0.9600
open $0.9500 now $0.9100
-$0.0400 (-4.21%)
Past week
$0.9300 $1.1000
from $1.0900 now $0.9100
-$0.1800 (-16.51%)
Past month
$0.8163 $1.1600
from $1.1500 now $0.9100
-$0.2400 (-20.87%)
This year
$0.8163 $8.9600
from $6.7800 now $0.9100
-$5.8700 (-86.58%)

Price & Performance

-4.79 (-84.04%) / 6M

$0.4086$2.65$4.89$7.13Apr 27Jul 28Oct 26

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.1% away from all-time highs of $101.2500
  • CVKD is down 87% since the beginning of the year
  • CVKD is down 94% over the past 12 months
  • CVKD is down 21% over the past 1 month
  • 3% of all CVKD investors are betting against CVKD

CVKD reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -93.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.14
Earnings momentum -24.8% Quarterly EPS growth
Quarterly change -24.8%

Valuation

P/E ratio N/A
Enterprise value $408.6K
Beta 2.14

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$2.4M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $3.7M

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $444.63 +1.22%
MRNA Moderna, Inc. $198.85 -0.62%
RVMD Revolution Medicines, Inc. $183.90 -1.65%
ROIV Roivant Sciences Ltd. $36.05 -1.21%
BNTX BioNTech SE Sponsored ADR $86.86 -1.42%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.